epidemiologic studies

Related by string. Epidemiologic studies * Epidemiologic : Epidemiologic Catchment Area . disseminates epidemiologic . National Epidemiologic Survey . landmark epidemiologic . epidemiologic surveillance / STUDIES . Studies . Studie : Religious Studies . Forced Migration Studies . Immigration Studies . Graduate Studies . Continuing Studies * Epidemiologic Studies Depression *

Related by context. All words. (Click for frequent words.) 77 epidemiological studies 75 observational studies 69 epidemiologic 68 longitudinal studies 68 meta analysis 67 randomized controlled trials 65 randomized trials 65 Observational studies 65 meta analyzes 65 placebo controlled studies 64 subgroup analyzes 64 ConclusionThis 64 placebo controlled trials 63 randomized controlled clinical trials 63 Epidemiological studies 63 epidemiological 63 studies 63 randomized clinical trials 62 randomized controlled trials RCTs 62 metaanalysis 62 Meta analyzes 62 RCTs 62 Epidemiologic studies 61 observational study 61 multicenter trials 61 selenium supplementation 60 prospective cohort 60 methodological limitations 60 VADT 60 susceptibility loci 60 nonrandomized 60 retrospective observational study 60 neuroimaging studies 59 correlational 59 unmeasured confounders 59 inverse association 59 familial clustering 59 dietary intakes 58 Longitudinal studies 58 retrospective cohort 58 beta carotene supplementation 58 IMPROVE HF 58 DHA supplementation 58 colorectal neoplasia 58 neuropsychiatric symptoms 58 chest radiographs 58 biologic plausibility 58 folate intake 58 retrospective cohort study 58 Subgroup analyzes 58 prospective observational studies 58 univariate analyzes 58 UKPDS 57 vitro studies 57 Cochrane reviewers 57 randomized clinical 57 placebo controlled clinical trials 57 chemoprevention trials 57 ExTRACT TIMI 57 generalisability 57 trials RCTs 57 probiotic supplementation 57 methodologic 57 longitudinal study 57 GBA mutations 57 utero exposure 57 SIBO 57 study 57 serum vitamin D 57 Wisconsin Sleep Cohort 56 INTERHEART study 56 generalizability 56 calcium supplementation 56 carotid atherosclerosis 56 NHANES III 56 prenatal exposures 56 thyrotropin levels 56 prospective longitudinal 56 SORT OUT III 56 Multiple logistic regression 56 meta regression 56 substudy 56 Cochrane Systematic Review 56 meta analytic 56 inactivated influenza vaccines 56 genetic polymorphisms 56 endotoxin exposure 56 liver transplant recipients 56 NHANES 56 observational cohort 56 magnesium intake 56 unmeasured factors 56 coronary calcification 56 clinicopathological 56 logistic regression analyzes 56 PM#.# exposure 56 prospective observational 56 vitamin supplementation 56 dietary antioxidants 56 NICE SUGAR 56 sputum specimens 55 etiologic 55 cardioprotective effects 55 prospective observational cohort 55 biochemical abnormalities 55 allergic sensitization 55 fructose intake 55 randomized controlled trial 55 NNRTI resistance 55 Conclusions 55 Dietary intake 55 causal inference 55 immunohistochemical 55 riociguat 55 methodological flaws 55 residual confounding 55 journal CHEST 55 plasma pharmacokinetics 55 vitro experiments 55 adiponectin levels 55 antioxidant supplements 55 colorectal adenoma 55 elevated homocysteine 55 folate deficiency 55 chromium supplementation 55 multivariate analyzes 55 STEP BD 55 biologically plausible 55 confounder 55 Diabetologia 55 colorectal adenomas 55 toxicological studies 55 genotype phenotype 55 developmental neurotoxicity 55 pharmacokinetic studies 55 serum leptin 55 Intervention Trial GAIT 55 prostate carcinogenesis 55 Dr. Yolton 55 multiple logistic regression 55 dietary intake 55 antioxidant supplementation 55 psychiatric morbidity 55 eculizumab therapy 55 epidemiologically 55 lipid abnormalities 54 pharmacokinetic PK 54 methodologically rigorous 54 androgen suppression 54 MGUS 54 Atherosclerosis MESA 54 flavonoid intake 54 Logistic regression analysis 54 subclinical atherosclerosis 54 comorbid depression 54 magnesium supplementation 54 genetic variants associated 54 multicentre study 54 journal Epidemiology 54 genomewide 54 Clinical Antipsychotic Trials 54 orofacial clefts 54 prucalopride 54 gross hematuria 54 abnormal glucose tolerance 54 multicenter study 54 elevated CRP 54 cerebral microbleeds 54 Randomized trials 54 neurodevelopmental outcome 54 folate supplementation 54 Multivariate logistic regression 54 dietary acrylamide 54 basal cell nevus syndrome 54 Vitamin D supplementation 54 subclinical hypothyroidism 54 CLBP 54 Boston DbTechNo Results 54 generalisable 54 airway responsiveness 54 macrovascular disease 54 familial aggregation 54 genetic loci 54 etiological factors 54 β blockers 54 nonrandomized studies 54 causal pathways 54 lignan intake 54 PROactive study 54 BARI 2D 54 randomized controlled clinical 54 newer atypical antipsychotics 54 multivariable analysis 54 ascertainment bias 54 hypoglycemic episodes 54 phthalate exposure 54 statistically significant correlations 54 BRFSS 54 convergent validity 54 underdiagnosis 54 Framingham Offspring Study 54 multicenter 54 multicentre 54 cardioembolic stroke 54 stone formers 54 intestinal biopsy 54 genomewide association study 53 #F FDG PET 53 depressive symptomatology 53 histopathological 53 urothelial cancer 53 multivitamin supplementation 53 Interphone study 53 genetic determinants 53 serologic testing 53 atherogenic dyslipidemia 53 serum cholesterol 53 nonpregnant women 53 immunohistochemical staining 53 myocardial infarctions 53 acrylamide intake 53 ECASS 53 serologic 53 silent myocardial ischemia 53 prevalences 53 dietary questionnaires 53 prospective randomized controlled 53 hydroxyvitamin D levels 53 CLA supplementation 53 lipid lowering therapy 53 GFT# 53 alexithymia 53 RSV bronchiolitis 53 interstitial lung abnormalities 53 bile acid metabolism 53 echogenic foci 53 Kaplan Meier curve 53 study1 53 inflammatory biomarkers 53 follicular adenoma 53 dietary patterns 53 Hertz Picciotto 53 HORIZONS AMI trial 53 clinicopathologic 53 pharmacologic treatments 53 pharmacological interventions 53 dietary interventions 53 #q# deletion 53 PLCO trial 53 phylogenetic analyzes 53 Cognitive impairment 53 KRAS variant 53 Intervention Effectiveness CATIE 53 subclinical hyperthyroidism 53 AVERROES 53 nutrient supplementation 53 Multivariate analysis 53 immunological responses 53 enterotypes 53 conditional logistic regression 53 colorectal carcinogenesis 53 pharmacokinetic pharmacodynamic 53 Digital Mammographic Imaging 53 journal Ophthalmology 53 Systematic reviews 53 cystatin C 53 atherothrombotic disease 53 antitumor effect 53 longitudinal cohort 53 schizophreniform disorder 53 longitudinal cohort study 53 vitamin D inadequacy 53 thorough QT 53 neuropsychological impairments 53 interobserver 53 vivo experiments 53 neurological abnormalities 53 sonographic findings 53 pathogenetic mechanisms 53 prospective multicentre 53 logistic regression models 53 folic acid supplementation 53 fluvastatin 53 comorbid psychiatric disorders 53 serum GGT 53 aldosterone antagonist 53 oseltamivir resistance 53 oncologic outcomes 53 pharmacokinetic interaction 53 Navas Acien 53 topical NSAIDs 53 cardiac biomarkers 53 prognostic significance 53 ginkgo biloba extract 53 journal Rheumatology 53 Multiethnic Study 53 NEJM 53 NO# [002] 53 S. maltophilia 53 telomere lengths 53 nomograms 53 adjuvant therapies 53 APOE genotype 53 scintigraphic 53 autonomic dysfunction 53 etiologies 53 NHAMCS 53 atypical neuroleptics 53 HOPE TOO 53 serum cotinine levels 52 neuropsychological impairment 52 gallstone disease 52 fasting glucose levels 52 intravenous bisphosphonates 52 PNH patients 52 histologic examination 52 surrogate markers 52 RE LY 52 Intervention Trial 52 CAMMS# 52 MERLIN TIMI 52 airway hyperresponsiveness 52 authors conclude 52 placebo controlled clinical 52 carotid IMT 52 dietary folate 52 metabolic parameters 52 atopic diseases 52 REACH Registry 52 pancreatic carcinogenesis 52 WTCCC 52 dietary calcium intake 52 INTERHEART 52 enterovirus infection 52 CALGB 52 studies GWAS 52 CTEPH 52 penetrance 52 chromosomal aberrations 52 Mechanistic studies 52 APOE e4 52 genetic locus 52 infantile colic 52 Nissen meta analysis 52 GRNCM1 52 bivariate analyzes 52 HAART regimens 52 microRNA expression 52 homocysteine concentrations 52 dose proportionality 52 intracerebral haemorrhage 52 mechanistic studies 52 KIF6 carriers 52 metabolic abnormalities 52 Communities ARIC study 52 commonly prescribed antidepressants 52 reflux symptoms 52 spontaneous regression 52 myopathy rhabdomyolysis 52 acute myocardial infarction MI 52 microbiologic 52 chronic rhinosinusitis 52 Cochrane Database 52 LC#m# vaccine 52 rhinovirus infections 52 virological response 52 genomewide association studies 52 physiologic mechanisms 52 HRQL 52 cranial irradiation 52 PREVENT IV 52 paricalcitol 52 Vauthey 52 FDG PET scans 52 landmark ATHENA study 52 CARDIA study 52 biomonitoring studies 52 prospectively defined 52 Adverse effects 52 Previous observational studies 52 pharmacodynamic PD 52 HIV HCV coinfected 52 genetic polymorphism 52 ATACAND 52 Skin sterol 52 multivariate regression analysis 52 serum markers 52 randomized multicenter trial 52 thromboprophylaxis 52 aetiology 52 nondiabetic patients 52 prostate cancer CaP 52 statistical correlations 52 waterpipe smoking 52 RSD# oral 52 Genetic predisposition 52 creatine supplementation 52 vivo assays 52 enteroviral infection 52 thiazide diuretics 52 Univariate analysis 52 regression analyzes 52 Depressive symptoms 52 logistic regression model 52 anthropometric measurements 52 choline intake 52 antihypertensive therapy 52 myocardial infarctions MIs 52 Swedish Mammography Cohort 52 IgA deficiency 52 urodynamic studies 52 asthma exacerbations 52 confounders 52 statistically significant correlation 52 sociodemographic 52 montelukast 52 elevated triglyceride levels 52 Chlamydia pneumoniae 52 macronutrient intake 52 testosterone supplementation 52 generalizable 52 journal Resuscitation 52 serologic tests 52 atopy 52 dose Iluvien 52 HNSCC 52 psychometric properties 52 neuropathologic 52 pentoxifylline 52 Rigorous scientific 52 sonographic diagnosis 51 immunohistochemical analysis 51 radiographic findings 51 obese postmenopausal 51 occupational exposures 51 Netherlands Cohort Study 51 dimensional sonography 51 multicenter randomized 51 multicentre prospective 51 genotypic 51 subanalysis 51 carotid bruit 51 antiepileptics 51 skin sterol 51 serum concentrations 51 inhaled corticosteroid therapy 51 prenatal phthalate exposure 51 KRAS status 51 Lactobacillus GG 51 methodological shortcomings 51 habitual snoring 51 Lp PLA2 51 angiographically 51 biological plausibility 51 RRMS patients 51 F FDG PET 51 diagnosing ADHD 51 postmarketing surveillance 51 multivariate Cox 51 NATRECOR ® 51 NSDUH 51 liver biopsies 51 APOE ε4 51 histologic findings 51 urate levels 51 serum lipid levels 51 cardiometabolic risk 51 callous unemotional traits 51 Study AREDS 51 chromium supplements 51 cardiovascular mortality 51 artifactual 51 Edge STudy 51 clinically meaningful differences 51 phase IIIb 51 Randomized clinical trials 51 intraobserver 51 SYNTAX trial 51 murine models 51 affective disorders 51 multivariate logistic regression 51 carotid stenosis 51 transient elastography 51 bone scintigraphy 51 IGRAs 51 prospective multicenter study 51 tHcy 51 FDG PET imaging 51 FOSRENOL ® 51 Bonferroni correction 51 ischemic cardiovascular 51 Logistic regression 51 microarray gene expression 51 phylogenetic analysis 51 confounding variables 51 ALLHAT 51 mesotheliomas 51 clinically insignificant 51 deferiprone 51 perinatal outcomes 51 paleoclimatic 51 antiplatelet drugs 51 Multi Ethnic Study 51 glucose abnormalities 51 molecular phylogenetic 51 etiologic factors 51 clinico pathological 51 iPrEx study 51 Randomised controlled trials 51 NESARC 51 pathophysiological mechanisms 51 clinical pharmacology studies 51 TCF#L# gene 51 intensive statin therapy 51 statistically nonsignificant 51 SGAs 51 prospective randomized 51 acetabular dysplasia 51 KIF6 gene variant 51 cryptogenic 51 ALB # 51 histopathologic 51 statin medications 51 CC genotype 51 RoACTEMRA 51 elevated bilirubin 51 selenium intake 51 multicentric 51 atopic sensitization 51 PLCO 51 actigraphy 51 metabolic dysfunction 51 antiplatelet therapies 51 nulliparous women 51 tumor histology 51 oral rivaroxaban 51 nondemented 51 pathophysiologic 51 hsCRP levels 51 QTc prolongation 51 papillary renal cell carcinoma 51 comorbidity 51 randomized controlled 51 Univariate 51 spirometric 51 thyroid dysfunction 51 genotypic resistance 51 prospective nonrandomized 51 cotinine levels 51 serum selenium 51 Nutrition Examination Surveys NHANES 51 microbleeds 51 researchers 51 preoperative evaluation 51 pulmonary toxicity 51 obesity insulin resistance 51 biochemical markers 51 Singh Manoux 51 abdominal adiposity 51 Boffetta 51 isoflavone supplement 51 singleton pregnancies 51 Hib vaccination 51 vitamin D deficiency 51 radiographic outcomes 51 B vitamin supplementation 51 genetic susceptibilities 51 pharmacoeconomic analysis 51 anecdotal observations 51 Subgroup analysis 51 DCE MRI 51 observational cohort study 51 gene polymorphisms 51 SE alleles 51 urolithiasis 51 APOL1 51 carotid plaque 51 differentially expressed genes 51 paclitaxel eluting stents 51 randomized placebo controlled 51 cardiovascular morbidity 51 Screening Trial DMIST 51 HER2 expression 51 GYTS 51 Statistical analyzes 51 myocardial dysfunction 51 familial pancreatic cancer 51 #OHD levels 51 mtDNA mutations 51 dietary carbohydrate 51 eosinophil count 51 inferential statistics 51 Boden Albala 51 BOLDER II 51 CARDIA 51 TAXUS VI 51 EEG abnormalities 51 ASD prevalence 51 G allele 51 serum cotinine 51 chronic periodontitis 51 bezafibrate 51 radiographic examinations 51 stratifying patients 51 clefting 51 meta analysis pooling 51 DHEA supplementation 51 CHARISMA trial 51 beta carotene supplements 51 intracerebral hemorrhage 51 BLLs 51 Kozyrskyj 51 serum lipids 51 fluoroquinolone resistance 51 environmental toxicants 51 double blinded randomized 51 adenotonsillectomy 51 Multiethnic Cohort Study 51 BoNTA 51 dyslipidaemia 50 CVD mortality 50 microbiomes 50 PECARN 50 histologic subtypes 50 BRCA testing 50 INTERPHONE 50 impaired insulin secretion 50 nutrient intakes 50 Systematic Review 50 Calcium intake 50 CSF biomarkers 50 chromium picolinate supplementation 50 neurodevelopmental outcomes 50 C. pneumoniae 50 dietary sodium 50 pharmacokinetic parameters 50 Dr. Pasinetti 50 Carotid Revascularization Endarterectomy vs. 50 filaggrin mutations 50 prostate cancer PCa 50 metabolomic profiling 50 Ascherio 50 missense mutations 50 glycemia 50 retrospective observational 50 exploratory endpoints 50 NOMID 50 hyperintense lesions 50 peer reviewed literature 50 covariate 50 differential gene expression 50 gut microbiota 50 Primary endpoints 50 SRBD 50 BERKELEY CA UroToday.com 50 DMIST 50 serum uric acid 50 antiepileptic drugs AEDs 50 journal Lancet Neurology 50 Cholesterol Levels SPARCL 50 histopathologic diagnosis 50 journal Clinical Gastroenterology 50 dysglycemia 50 predisposing factor 50 Multiple linear regression 50 exhaled nitric oxide 50 XMRV infection 50 multicenter Phase II 50 Lp PLA 2 50 #:#-# [035] 50 toxicologic 50 BMC Biology 50 bacterial isolates 50 antidiabetic therapy 50 flavonoid rich 50 HF ACTION 50 RE LY ® 50 non fasting triglycerides 50 parkinsonian symptoms 50 chorioamnionitis 50 #,# DCB 50 secretin 50 EDEMA3 trial 50 etiological 50 Health HSPH 50 familial predisposition 50 randomized multicenter 50 neurocognitive deficits 50 iodine intake 50 chimp genomes 50 causal link 50 carcinogenicity studies 50 amyloid deposition 50 inflammatory rheumatic 50 atopic 50 viral kinetic 50 intima media thickness IMT 50 lactose malabsorption 50 latent celiac disease 50 congenital malformations 50 methodological weaknesses 50 ragweed allergic 50 preoperative diagnosis 50 serological 50 autistic enterocolitis 50 ACOSOG Z# 50 neuroprotective effects 50 pathologic fractures 50 underlying pathophysiology 50 central adiposity 50 GAMMAGARD 50 GSTM1 50 vitamin D supplementation 50 Phase IIIb study 50 hematopoietic cancers 50 perilipin 50 Kaplan Meier analysis 50 preclinical efficacy 50 fetuin 50 NAFLD 50 esophageal squamous cell carcinoma 50 comorbid conditions 50 intact parathyroid hormone 50 serum folate concentrations 50 recurrent venous thromboembolism 50 CHD mortality 50 Phylogenetic analyzes 50 chromosomal anomalies 50 proliferative diabetic retinopathy 50 AJPH 50 CT perfusion 50 nonmelanoma skin cancers 50 CARE HF 50 coinfection 50 Francesca Bravi 50 genomic deletions 50 OSAHS 50 explanatory variables 50 Meta Analysis 50 monogenic 50 journal Gut 50 RBC folate 50 anthropometric measures 50 vertebral fracture 50 colorectal neoplasms 50 thimerosal exposure 50 serum biomarkers 50 E. faecalis 50 journal Diabetologia 50 herpes zoster vaccine 50 oxysterols 50 epithelial tumors 50 serum retinol 50 rs# [002] 50 pharmacokinetics PK 50 vascular dysfunction 50 PPSV# 50 Prostate Lung Colorectal 50 univariate 50 fluoroquinolone resistant 50 Nutrition Examination Survey NHANES 50 Multivariate analyzes 50 histologic diagnosis 50 multicenter placebo controlled 50 left ventricular dysfunction 50 newer antipsychotics 50 dose statin therapy 50 Randomized Controlled Trials 50 psychiatric outpatients 50 posttreatment 50 Hashibe 50 carotid plaques 50 neurologic disorders 50 Dr. Beilharz 50 CANCIDAS 50 Evaluation WISE 50 DQB1 * 50 Torsades de Pointes 50 advanced adenoma 50 SEER database 50 multivariate analysis 50 acid suppressive medication 50 subclinical 50 HYVET 50 Regression analyzes 50 CYPHER R Sirolimus eluting 50 nonpharmacologic 50 Pharmacokinetic PK 50 transcriptomic 50 FFQ 50 pharmacodynamic properties 50 plasma selenium 50 predictive validity 50 thiopurine 50 MDRD equation 50 thrombophilia 50 NSQIP 50 Phase #/#a 50 biologic pathways 50 antibiotic prophylaxis 50 atherosclerotic vascular disease 50 antihypertensive drugs 50 selenium supplements 50 delayed gastric emptying 50 STRIDE PD 50 histological subtypes 50 dietary carotenoids 50 hydroxyvitamin D concentrations 50 silymarin 50 logistic regression analysis 50 cognitive domains 50 sCJD 50 poststroke depression 50 BRCA1 mutations 50 nodal metastases 50 perfusion abnormalities 50 induced sputum 50 Dietary Modification Trial 50 coronary artery calcium 50 postoperative complications 50 aminotransferases 50 serum IgE 50 pharmacodynamic parameters 50 nesiritide 50 rBChE 50 PROSTVAC TM 50 pyridostigmine 50 Cochrane Collaboration 50 immunopathology 50 non affective psychosis 50 morphometric vertebral fractures 50 sputum induction 50 PRECiSE 50 BPS IC 50 susceptibility locus 50 prognostic indicators 50 leiomyomas 50 elevated triglycerides 50 cholestasis 50 Bifidobacterium infantis # 50 pharmacodynamics PD 50 rs# [001] 50 extrapyramidal symptoms 50 fetal malformations 50 motor neuron degeneration 50 randomized crossover 50 chest radiography 50 immunocompetent 50 Microscopic examination 50 trans palmitoleate 50 nonfasting triglycerides 50 HIVNET 50 statistically significant 50 IPAH 50 diabetes mellitus 50 nonfasting 50 symptomatic VTE 50 Multivariable logistic regression 50 BUSM researchers 50 coinfected patients 50 journal Appetite 49 ONTARGET 49 SPARCL 49 linear regression analyzes 49 Wactawski Wende 49 phase Ib 49 hypovitaminosis D 49 polymorphisms 49 ACCORD ADVANCE 49 T1DM 49 Intervention Effectiveness 49 Electrophysiological 49 Deutsches Arzteblatt International 49 virologic 49 gastric adenocarcinoma 49 noscapine 49 multicentre randomized 49 Natural S equol 49 genetic variants 49 metabolite concentrations 49 nonsignificant 49 bowel polyps 49 hereditary predisposition 49 urinary concentrations 49 Shanna Swan 49 MMP inhibitors 49 darbepoetin alpha 49 circadian disruption 49 microdeletions 49 APOE allele 49 Dietary intakes 49 chronic pancreatitis 49 colorectal tumors 49 gallium nitrate 49 polyp recurrence 49 #:#-# [029] 49 MADIT CRT trial 49 HCV SPRINT 49 Tsimikas 49 semiquantitative 49 LVNC 49 viral etiology 49 BJU International 49 interindividual variability 49 non aspirin NSAIDs 49 prenatal exposure 49 peer reviewed 49 psychiatric comorbidities 49 spontaneous preterm delivery 49 esophageal reflux 49 postmenopausal hormone therapy 49 WHEL 49 arteriography 49 elevated ALT 49 arachidonic acid AA 49 FDG PET 49 Winkelmayer 49 IQWiG 49 journal Atherosclerosis 49 neurocognitive functioning 49 Susanna Larsson 49 brain lesions 49 Hepatotoxicity 49 modifiable risk 49 pesticide exposures 49 miRNA expression 49 non selective NSAIDs 49 lipid lowering medications 49 BETAS 49 neurocognitive impairment 49 Pharmacokinetic 49 atherosclerotic lesions 49 HMG CoA reductase inhibitors 49 vitamin D intake 49 atherothrombotic 49 metabolic syndrome MetS 49 dose ionizing radiation 49 TQT studies 49 SNP rs# [001] 49 plasma adiponectin 49 plasma lipids 49 active comparator 49 ACUITY trial 49 renal tumors 49 neuroprotective properties 49 noncardiac 49 thyroid nodules 49 dietary sodium intake 49 journal Behavioral Neuroscience 49 journal PloS ONE 49 SNP rs# [002] 49 organophosphate exposure 49 Serious Adverse Events 49 microarray datasets 49 intracranial stenosis 49 serum calcium 49 osteosarcomas 49 confounding factors 49 thromboembolism 49 interobserver reliability 49 cortical thinning 49 cardioprotective effect 49 dietary fructose 49 postoperative mortality 49 serological tests 49 artery calcification 49 gene variants 49 Chodick 49 neuroanatomical 49 dyslipidemias 49 statistical analyzes 49 nonclinical studies 49 dosage regimens 49 Genetic variants 49 CYP #A# 49 untreated celiac disease 49 cTnT levels 49 narcolepsy cataplexy 49 comorbid disorders 49 Tumor Response 49 pharmacological approaches 49 bone metabolism 49 oxidized phospholipids 49 placebo controlled 49 plasma lipid 49 antidepressant efficacy 49 impaired glucose metabolism 49 myocardial uptake 49 Multicenter AIDS 49 dietary glycemic index 49 ß carotene 49 MenSCs 49 diabetes mellitus hypertension 49 microalbumin 49 polyarticular 49 hyperglycaemia 49 somatic mutations 49 Fasting glucose 49 HRQOL

Back to home page